Insiders Protara Therapeutics, Inc.

Equities

TARA

US74365U1079

Real-time Estimate Cboe BZX Other stock markets 03:24:09 2024-04-29 pm EDT			5-day change	1st Jan Change
3.1 ^USD	+5.98%		+0.65%	+63.72%

Apr. 22	Oppenheimer Adjusts Protara Therapeutics Price Target to $30 From $26	MT
Apr. 05	Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Protara Therapeutics, Inc. Announces Resignation of Jathin Bandari as Chief Medical Officer, Effective April 11, 2024	Mar. 18	CI
Protara Therapeutics Names Patrick Fabbio Financial Chief	23-01-30	MT
Protara Therapeutics Announces Appointment of Patrick Fabbio as Chief Financial Officer	23-01-30	CI
Selecta Biosciences Names Blaine Davis CFO	22-11-28	MT
Protara Therapeutics, Inc. Appoints Hannah Fry as Controller and Principal Accounting Officer	22-07-18	CI
Protara Therapeutics Finance Chief Blaine Davis to Depart in July	22-06-21	MT
Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer	22-01-10	CI
Protara Therapeutics, Inc. Announces Management Changes	21-10-18	CI
Protara Therapeutics Announces Appointment of Jane Huang to Board of Directors	21-06-10	CI
Protara Therapeutics Inc. Appoints Martín Sebastian Olivo as Chief Medical Officer	21-04-19	CI
Protara Therapeutics, Inc. Appoints Cynthia Smith as Class Iii Director	21-02-02	CI
Protara Therapeutics, Inc. Announces Promotion of Jacqueline Zummo to the Role of Chief Scientific Operations Officer, Effective January 1, 2021	20-12-07	CI
Protara Therapeutics, Inc. Announces Board Changes	20-07-24	CI
ArTara Therapeutics, Inc. has Changed its Name to Protara Therapeutics, Inc	20-05-11	CI
Proteon Therapeutics, Inc. Announces Executive Changes	20-01-10	CI
Jesse Shefferman, Chief Executive Officer Leads ArTara Therapeutics, Inc	20-01-09	CI
ArTara Therapeutics Announces Appointments to Board of Directors	19-12-19	CI
Proteon Therapeutics, Inc. Announces Board and Committee Changes	19-04-15	CI
ArTara Therapeutics Announces Management Appointments	19-02-04	CI
ArTara Therapeutics Announces Addition of Randall Marshall, MD as Chief Medical Officer and President of Research & Development	18-01-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Protara Therapeutics, Inc.

Equities

TARA

US74365U1079

Insiders

Filters